Pharming Group (CHIX:PHARMa)
€ 0.7515 0 (0%) Market Cap: 501.38 Mil Enterprise Value: 468.90 Mil PE Ratio: 0 PB Ratio: 2.69 GF Score: 81/100

Q4 2021 Pharming Group NV Earnings Call Transcript

Mar 17, 2022 / 01:00PM GMT
Release Date Price: €0.891
Operator

Hello, and welcome to Pharming's Full Year 2021 Results Call. My name is Jordan, and I'll be coordinating your call today. (Operator Instructions)

I'm now going to hand over to Pharming's CEO, Sijmen de Vries, to begin. Sijmen, please go ahead.

Sijmen de Vries
Pharming Group N.V. - President, CEO & Executive Director

Thank you very much, Jordan.

Good morning and good afternoon, ladies and gentlemen, and welcome to our full year results conference. I have here with me our CFO, Jeroen Wakkerman; and our Chief Medical Officer, Anurag Relan. We will be taking you through a short presentation. Of course, there's questions and answers afterwards. But before I do that, I would like you to take a look at the next slide with the forward-looking statements as we will be making some forward-looking statements that are based on our current beliefs and assumptions and expectations, and those can obviously, as you know, change.

So let's just move on to the next slide. And there, you see some pictures of us and maybe we can move on to Slide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot